stockrowArrowhead Pharmaceuticals, Inc.
ARWR Healthcare Biotechnology
Arrowhead Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $829.4 million, up 23,258.2% from fiscal 2024.
- Revenue
- +171.0%
- EPS
- −7.94%
- Free cash flow
- −15.4%
- Total debt
- +259.5%
Quarter to June 2026, against a year earlier
Follow ARWR
Alert me
Arrowhead Pharmaceuticals, Inc. (ARWR) Operating margin
Arrowhead Pharmaceuticals, Inc.'s operating margin over the twelve months to 30 June 2026 was −33.8%, down 45.7 percentage points from fiscal 2025 (11.9%). Over the past ten years it has ranged from −51,637.8% (fiscal 2016) to 36.3% (fiscal 2019); the current reading is higher than 91% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 11.9% | 16,938.92 |
| FY2024 | −16,927.1% | (16,841.90) |
| FY2023 | −85.2% | (11.77) |
| FY2022 | −73.4% | 34.38 |
| FY2021 | −107.8% | (1.90) |
| FY2020 | −105.9% | (142.12) |
| FY2019 | 36.3% | 382.77 |
| FY2018 | −346.5% | (228.73) |
| FY2017 | −117.8% | 51,520.05 |
| FY2016 | −51,637.8% | (26,513.76) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −226.0% | (34.46) |
| Mar 2026 | −191.6% | (207.03) |
| Dec 2025 | 15.5% | (1.74) |
| Sep 2025 | 17.2% | 613.41 |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| KRYS Krystal Biotech, Inc. compare | 48.4% |
| PTGX Protagonist Therapeutics, Inc. compare | 20.7% |
| CAI Caris Life Sciences,�Inc. compare | 13.4% |
| CORT Corcept Therapeutics Incorporated compare | 11.5% |
| SYRE Spyre Therapeutics, Inc. compare | 0.00% |
| MDGL Madrigal Pharmaceuticals, Inc. compare | −10.7% |
| TWST Twist Bioscience Corporation compare | −33.6% |
| ARWR Arrowhead Pharmaceuticals, Inc. | −33.8% |
| CYTK Cytokinetics, Incorporated compare | −625.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ARWR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement